Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

537
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
537
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

480
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
480
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

309
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
309
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

491
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
491
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

903
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
903
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

426
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
426

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin for COVID-19: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Reviews in medical virology·2026
Same author

Evaluating Modified Early Warning Score Compliance to Minimize Unnecessary Intensive Care Unit Admissions: A Descriptive Cross-Sectional Needs Assessment at a University Teaching Tertiary Care Centre to Inform Quality Improvement Implementation.

Journal of evaluation in clinical practice·2026
Same author

How to Use Multimodality Imaging for Pericarditis.

Circulation. Cardiovascular imaging·2026
Same author

Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis.

Methodist DeBakey cardiovascular journal·2026
Same author

Contemporary Review of Clinical Features, Multi-Modality Imaging, and Management of Pericardial Cysts.

Journal of clinical medicine·2026
Same author

Contemporary Trends, In-Hospital Outcomes, and Adverse Prognosticators of Sickle Cell Patients with Cardiovascular and Thromboembolic Complications: A National Database Analysis.

Angiology·2026

Related Experiment Video

Updated: Mar 17, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

12.1K

Relapsing Pericarditis: Prediction of Relapses, Risk Scores, and Role of Exercise Restriction.

Joseph El Roumi1, Jibran Ikram1, Tom Kai Ming Wang1

  • 1Center for Diagnosis and Treatment of Pericardial Diseases, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Methodist Debakey Cardiovascular Journal
|March 16, 2026
PubMed
Summary

Relapsing pericarditis (RP) is a recurring inflammatory heart condition. This review covers predictors, risk scores, and exercise strategies for managing RP to improve patient outcomes.

Keywords:
acute pericarditisexercise restrictionrecurrent pericarditisrisk factorsrisk scores

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K
Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

5.7K

Related Experiment Videos

Last Updated: Mar 17, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

12.1K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K
Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

5.7K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Inflammatory Diseases

Background:

  • Relapsing pericarditis (RP) is characterized by recurrent acute pericarditis flares.
  • RP affects 15-30% of initial acute pericarditis cases, with high recurrence rates.
  • RP leads to significant morbidity, reduced quality of life, and potential complications like cardiac tamponade.

Purpose of the Study:

  • To review current knowledge on clinical perspectives, predictors, and risk stratification for RP relapses.
  • To critically evaluate the role of exercise restriction in RP management.
  • To summarize evolving strategies for treating relapsing pericarditis.

Main Methods:

  • Literature review of clinical trials, observational studies, and expert experiences in RP management.
  • Analysis of identified prognostic factors from clinical, laboratory, and imaging data.
  • Assessment of recently developed risk scores (Athens, Torino, INFLA, Klein) and exercise restriction guidelines.

Main Results:

  • Numerous adverse prognosticators for RP have been identified.
  • Several risk scores are available for RP risk stratification and treatment guidance.
  • Evidence supports individualized exercise restriction strategies within multimodal RP treatment.

Conclusions:

  • Multicenter validation and randomized trials are needed for risk scores and exercise restriction.
  • Improved understanding and application of risk stratification and exercise guidance can enhance RP patient outcomes.